Bill > H7177

This bill revises provisions related to the confidentiality of information held by the Department of Health (DOH) under the Prescription Drug Monitoring Program (PDMP), which tracks the dispensing of controlled substances to prevent abuse and diversion. Specifically, it clarifies that certain entities, such as law enforcement agencies and health care regulatory boards, can disclose confidential and exempt information from the PDMP if it is relevant to an active investigation into prescription drug abuse or diversion, but they must first take steps to ensure the confidentiality of any non-relevant information. The bill also changes the DOH's role from being required to disclose this information to being authorized to disclose it, and it saves the exemption from repeal, meaning it will continue to be in effect.